https://finance.yahoo.com/news/ionis-chief-scientific-officer-c-143000735.html
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Chief Scientific Officer C. Frank Bennett, Ph.D., has been named a co-recipient of the...
Create an account or login to join the discussion